Patient Guide: Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 18 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT05180097
Status: 🟢 Enrolling Now
Condition: Hodgkin Lymphoma
Phase: PHASE2

Where You Can Participate

This study is available at 18 locations across the country.

Top locations include:
  • • Concord, New South Wales
  • • Nowra, New South Wales
  • • Wollongong, New South Wales
  • • And 15 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

Pembrolizumab and Brentuximab Vedotin vs GDP and Stem Cell Transplant for Relapsed/Refractory Hodgkin Lymphoma - Join Clinical Trial NCTNCT05180097

How to Join This Clinical Trial - NCTNCT05180097

Learn how to participate in this PHASE2 trial studying an investigational therapy for Hodgkin Lymphoma. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Hodgkin Lymphoma. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Hodgkin Lymphoma
Treatment Being Tested
Investigational treatment
Study Phase
PHASE2 - Safety and effectiveness study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT05180097 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 18 locations. Find a study site near you:

Clinical Research Site

Concord, New South Wales 2139 - Australia

Status: RECRUITING

Clinical Research Site

Nowra, New South Wales 2541 - Australia

Status: RECRUITING

Clinical Research Site

Wollongong, New South Wales 2500 - Australia

Status: RECRUITING

Clinical Research Site

Adelaide, South Australia 5000 - Australia

Status: RECRUITING

Clinical Research Site

Heidelberg, Victoria 3084 - Australia

Status: RECRUITING

Clinical Research Site

Perth, Western Australia 6009 - Australia

Status: RECRUITING

Clinical Research Site

Calgary, Alberta T2N 5G2 - Canada

Status: RECRUITING

Clinical Research Site

Vancouver, British Columbia V5Z 4E6 - Canada

Status: RECRUITING

Clinical Research Site

St. John's, Newfoundland and Labrador A1B 3V6 - Canada

Status: RECRUITING

Clinical Research Site

Halifax, Nova Scotia B3H 1V7 - Canada

Status: RECRUITING

And 8 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE2 clinical trial for Hodgkin Lymphoma:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships